Skip to main content
SpringerLink
Log in

Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: Evaluation of E5324, an Acyl-CoA cholesterol acyltransferase inhibitor

  • Article
  • Published:
Lipids

Abstract

Cholesteryl esters (CE) comprise the principal lipid class that accumulates within macrophages and smooth muscle cells of the atherosclerotic lesion. Acyl-CoA cholesterol acyl-transferase (ACAT) is the major enzyme responsible for esterification of intracellular cholesterol. We evaluated the ability of E5324 (n-butyl-N″-[-2-[3-(5-ethyl-4-phenyl-1H-imidazol-1-yl)propoxyl]-6-methyl-phenyllurea), a novel, orally absorbable ACAT inhibitor, to inhibit esterification of fatty acids to cholesterol and CE accumulation in macrophages and in smooth muscle cells. E5324 significantly inhibited cholesterol esterification in rat aortic smooth muscle cells and in macrophages. In addition, E5324 reduced the cellular mass of CE, the significant measure of the efficacy of drugs designed to modulate cholesterol metabolism. E5324 treatment of macrophages exposed to acetylated low-density lipoprotein reduced CE mass by 97%, and treatment of lipid-loaded smooth muscle cells reduced CE mass by 29%. Although free cholesterol increased approximately twofold, this free cholesterol would presumably be accessible to the membrane for effluxin vivo (reverse cholesterol transport). These results demonstrate that E5324 can inhibit cholesterol esterification and CE mass in atherosclerotic foam cells, derived from either macrophages or arterial smooth muscle cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACAT:

acyl-CoA cholesterol acyltransferase

ACEH:

acid cholesteryl ester hydrolase

CE:

cholesteryl ester

LDL:

low-density lipoprotein

NCEH:

neutral cholesteryl ester hydrolase

PBS:

phosphate-buffered saline

References

  1. Sliskovic, D., and White, A. (1991) Therapeutic Potential of ACAT Inhibitors as Lipid Lowering and Anti-Atherosclerotic Agents,Trends Pharm. Sci. 12, 194–199.

    Article  PubMed  CAS  Google Scholar 

  2. Suckling, K., and Stange, E. (1985) Role of Acyl-CoA: Cholesterol Acyltransferase in cellular Cholesterol Metabolism,J. Lipid Res. 26, 647–671.

    PubMed  CAS  Google Scholar 

  3. Gillies, P., Rathgeb, K., Perri, M., and Robinson, C. (1986) Regulation of Acyl-CoA: Cholesterol Acyltransferase Activity in Normal and Atherosclerotic Rabbits: Role of Cholesterol Substrate Pool,Expt. Mol. Pathol. 44, 329–339.

    Article  CAS  Google Scholar 

  4. Hashimoto, S., and Dayton, S. (1975) Influence of Microsomal Cholesterol Concentrations on the Cholesterol-Esterifying Activity of Normal and Atherosclerotic Aortas,Artery 1, 308–318.

    CAS  Google Scholar 

  5. Brecher, P., and Chobanian, A. (1974) Cholesteryl Ester Synthesis in Normal and Atherosclerotic Aortas of Rabbit and Rhesus Monkeys,Circ. Res. 35, 692–701.

    PubMed  CAS  Google Scholar 

  6. Kimura, T., Takase, Y., Hayashi, K., Tanaka, H., Ohtsuka, I., Saeki, T., Kogushi, M., Yamada, T., Fujimori, T., Saitou, I., and Akasaka, K. (1993) Structure-Activity Relationship ofN-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy]-N′-pentylurea and Analogues. Novel Potent Inhibitors of Acyl-CoA: CholesterolO-Acyltransferase with Antiatherosclerotic Activity,J. Med. Chem. 36, 1630–1640.

    Article  PubMed  CAS  Google Scholar 

  7. Kimura, T., Watanabe, N., Matsui, M., Hayashi, K., Tanaka, K., Ohtsuka, I., Saeki, T., Kogushi, M., Kabayashi, H., Akasaka, K., Yamagishi, Y., Saitou, I., and Yamatsu, I. (1993) Structure-Activity Relationship of a Series of Phenylureas Linked to 4-Phenylimidazole. Novel Potent Inhibitors of Acyl-CoA: CholesterolO-Acyltransferase with Antiatherosclerotic Activity 2,J. Med. Chem. 36, 1641–1653.

    Article  PubMed  CAS  Google Scholar 

  8. Kogushi, M., Ohtsuka, I., Tanaka, H., Kimura, T., Hayashi, K., Saito, I., and Yamatsu, I. (1992) I. E5324: A Potent and Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase, inProceedings of the XI International Symposium on Drugs Affecting Lipid Metabolism, p. 88 (abstract) Kluwer Academic Publishers, The Netherlands.

    Google Scholar 

  9. Tanaka, H., Ohtsuka, I., Kogushi, M., Kimura, T., Fugimori, T., Saeki, T., Hayashi, K., Yamada, T., Hiyoshi, H., and Saito, I. (1994) Effect of the Acyl-CoA:Cholesterol Acyltransferase Inhibitor, E5324, on Experimental Atherosclerosis in Rabbits,Athero. 107, 187–201.

    Article  CAS  Google Scholar 

  10. Katsuda, S., Boyd, H., Fligner, C., Ross, R., and Gown, A. (1992) Human Atherosclerosis III. Immunocytochemical Analysis of the Cell Composition in Young Adults,Amer. J. Pathol. 140, 907–914 (1992).

    CAS  Google Scholar 

  11. Brown, M., and Goldstein, J. (1983) Lipoprotein Metabolism in the Macrophage: Implications for Cholesterol Deposition in Atherosclerosis,Ann. Rev. Biochem. 52, 223–261.

    Article  PubMed  CAS  Google Scholar 

  12. Havel, R., Eder, H., and Bradgon, J. (1955) The Distribution and Chemical Preparation of Ultracentrifugally Separated Lipoproteins in Human Serum,J. Clin. Invest. 34, 1345–1353.

    PubMed  CAS  Google Scholar 

  13. Goldstein, J., Ho, Y., Basu, S., and Brown, M. (1979) Binding Site on Macrophages That Mediates the Uptake and Degradation of Acetylated Low Density Lipoprotein Producing Massive. Cholesterol Deposition,Proc. Natl. Acad. Sci. USA 76, 333–337.

    Article  PubMed  CAS  Google Scholar 

  14. Basu, S., Anderson, R., Goldstein, J., and Brown, M. (1977) Metabolism of Cationized Lipoproteins by Human Fibroblasts. Biochemical and Morphologic Correlations,J. Cell. Biol. 74, 119–135.

    Article  PubMed  CAS  Google Scholar 

  15. Basu, S., Goldstein, J., Anderson, R., and Brown, M. (1976) Degradation of Cationized Low Density Lipoprotein and Regulation of Cholesterol Metabolism in Homozygous Familial Hypercholesterolemia,Proc. Natl. Acad. Sci. USA 73, 3178–3182.

    Article  PubMed  CAS  Google Scholar 

  16. Brown, M., Ho, Y., and Goldstein, J. (1980) The Cholesteryl Ester Cycle in Macrophage Foam Cells: Continual Hydrolysis and Re-esterification of Cytoplasmic Cholesteryl Esters,J. Biol. Chem. 255, 9344–9352.

    PubMed  CAS  Google Scholar 

  17. Haley, N., Fowler, S., and deDuve, C. (1980) Lysosomal Acid Cholesteryl Esterase Activity in Normal and Lipid-laden Aortic Cells,J. Lipid Res. 21, 961–969.

    PubMed  CAS  Google Scholar 

  18. Hajjar, D. (1986) Regulation of Neutral Cholesteryl Esterase in Arterial Smooth Muscle Cells: Stimulation by Agonists of Adenylate Cyclase and Cyclic Amp-dependent Protein Kinase,Arch. Biochem. Biophys. 247, 49–56.

    Article  PubMed  CAS  Google Scholar 

  19. Pomerantz, K., and Hajjar, D. (1989) Eicosanoid Metabolism in Cholesterol-Enriched Arterial Smooth Muscle Cells: Reduced Arachidonate Release with Concommitant Decrease in Cyclooxygenase Products,J. Lipid Res. 30, 1219–1231.

    PubMed  CAS  Google Scholar 

  20. Lowry, O., Rosebrogh, N., Farr, A., and Randall, J. (1951) Protein Measurement with the Folin Phenol Reagent,J. Biol. Chem. 193, 265–275.

    PubMed  CAS  Google Scholar 

  21. Goldstein, J., Anderson, R., Buja, L., Basu, S., and Brown, M. (1977) Overloading Human Aortic Smooth Muscle Cells with Low Density Lipoprotein-Cholesteryl Esters Reproduces Features of Atherosclerosisin vitro, J. Clin. Invest. 59, 1196–1202.

    Article  PubMed  CAS  Google Scholar 

  22. Bocan, J., Mueller, S., Uhlendorf, P., Newton, R., and Krause, B., (1991) Comparison of CI-976, an ACAT Inhibitor, and Selected Lipid-Lowering Agents for Antiatherosclerotic Activity in Iliac-Femoral and Thoracic Aortic Lesions,Arterioscler. Thromb. 11, 1830–1843.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology and Biochemistry, Cornell University Medical College, 1300 York Ave, 10021, New York, New York

    Andrew C. Nicholson, Kenneth B. Pomerantz, Tohru Fujimori & David P. Hajjar

Authors
  1. Andrew C. Nicholson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth B. Pomerantz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tohru Fujimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David P. Hajjar
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Nicholson, A.C., Pomerantz, K.B., Fujimori, T. et al. Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: Evaluation of E5324, an Acyl-CoA cholesterol acyltransferase inhibitor. Lipids 30, 771–774 (1995). https://doi.org/10.1007/BF02537805

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02537805

Keywords

Search

Navigation